Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
21
pubmed:dateCreated
1990-12-7
pubmed:databankReference
pubmed:abstractText
Iduronate 2-sulfatase (IDS, EC 3.1.6.13) is required for the lysosomal degradation of heparan sulfate and dermatan sulfate. Mutations causing IDS deficiency in humans result in the lysosomal storage of these glycosaminoglycans and Hunter syndrome, an X chromosome-linked disease. We have isolated and sequenced a 2.3-kilobase cDNA clone coding for the entire sequence of human IDS. Analysis of the deduced 550-amino acid IDS precursor sequence indicates that IDS has a 25-amino acid amino-terminal signal sequence, followed by 8 amino acids that are removed from the proprotein. An internal proteolytic cleavage occurs to produce the mature IDS present in human liver shown to contain a 42-kDa polypeptide N-terminal to a 14-kDa polypeptide. The IDS sequence has strong sequence homology with other sulfatases (such as sea urchin arylsulfatase, human arylsulfatases A, B, and C, and human glucosamine 6-sulfatase), suggesting that the sulfatases comprise an evolutionarily related family of genes that arose by gene duplication and divergent evolution. The arylsulfatases have a greater homology with each other than with the non-arylsulfatases (IDS and glucosamine 6-sulfatase). The IDS cDNA detected RNA species of 5.7, 5.4, 2.1, and 1.4 kilobases in human placental RNA and revealed structural alterations and gross deletions of the IDS gene in many of the clinically severe Hunter syndrome patients studied.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/2122463-11645773, http://linkedlifedata.com/resource/pubmed/commentcorrection/2122463-2303452, http://linkedlifedata.com/resource/pubmed/commentcorrection/2122463-2440339, http://linkedlifedata.com/resource/pubmed/commentcorrection/2122463-2511208, http://linkedlifedata.com/resource/pubmed/commentcorrection/2122463-2562955, http://linkedlifedata.com/resource/pubmed/commentcorrection/2122463-2569156, http://linkedlifedata.com/resource/pubmed/commentcorrection/2122463-2668275, http://linkedlifedata.com/resource/pubmed/commentcorrection/2122463-271968, http://linkedlifedata.com/resource/pubmed/commentcorrection/2122463-2734293, http://linkedlifedata.com/resource/pubmed/commentcorrection/2122463-3032454, http://linkedlifedata.com/resource/pubmed/commentcorrection/2122463-3181160, http://linkedlifedata.com/resource/pubmed/commentcorrection/2122463-3196333, http://linkedlifedata.com/resource/pubmed/commentcorrection/2122463-3203382, http://linkedlifedata.com/resource/pubmed/commentcorrection/2122463-3313277, http://linkedlifedata.com/resource/pubmed/commentcorrection/2122463-3468507, http://linkedlifedata.com/resource/pubmed/commentcorrection/2122463-3611052, http://linkedlifedata.com/resource/pubmed/commentcorrection/2122463-3703684, http://linkedlifedata.com/resource/pubmed/commentcorrection/2122463-3714490, http://linkedlifedata.com/resource/pubmed/commentcorrection/2122463-44451, http://linkedlifedata.com/resource/pubmed/commentcorrection/2122463-958
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:volume
87
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
8531-5
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1990
pubmed:articleTitle
Hunter syndrome: isolation of an iduronate-2-sulfatase cDNA clone and analysis of patient DNA.
pubmed:affiliation
Department of Chemical Pathology, Adelaide Children's Hospital, Australia.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't